An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-8 | Issue-10
The Efficiency of Misoprostol versus Manual Vacuum Aspiration for the Treatment of Incomplete Abortion
Dr. Nasima Begum, Dr. Rokeya Begum, Dr. Khan Mashrequl Alam
Published: Oct. 13, 2020 | 132 161
DOI: 10.36347/sjams.2020.v08i10.011
Pages: 2260-2265
Downloads
Abstract
Objective: In this our main goal is to assess the efficiency of misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion. Method: This hospital based randomized controlled trial study was conducted in in-patient patient Department of Obstetrics and Gynaecology, Chittagong Medical College and Hospital from October 2007 to September 2008. A total of 128 women between the ages of 15 to 40 years with diagnosis of first trimester uncomplicated spontaneous incomplete abortion was included in this study. Among them 64 patients were randomized in group ‘A’ as case who were treated with Misoprostol and 64 patients were in group ‘B’ as control who were treated with Manual Vacuum Aspiration. Results: During the study, where the mean gestational size of uterus was 9.52 weeks at the time of initial examination. The mean size of uterus in misoprostol group was 9.07(SD ±1.93) and that of MVA group was 9.87 (SD± 1.35). More women in case group had no child of viable age on the other hand increased number of women in control group had at least one viable birth. 36 (60%) out of 60 women in misoprostol group 26 (41.93%) out of 62 reported pain and 36 (58.07%) out of 62 women in MVA and 24 (40%) patients in misoprostol arm said bleeding as the worst feature. Thirty six percent women in misoprostol group and 16% women in MVA group reported that the adverse effects were easily tolerable. Thirty percent women in Misoprostol arm and 29.03 % women in MVA arm were satisfied with their respective treatment. But only 3.23% patients in MVA arm while 53.30% women in Misoprostol arm were very satisfied with their allocated treatment. Fifty (83.3%) patients out of 60 in Misoprostol arm and 18 (29.03) out of 62 women in control group said that they would choose the method again if they face such a problem in future. When they were asked whether they would recommend it to their friends 93.3% patients in Misoprostol group and only 12.5% in MVA group said that they.........